Metastasis depends upon cancer cell growth and survival within the metastatic niche. 15
Introduction 5
Cell surface mucins, such as MUC1 and MUC16, are so consistently upregulated 6 in epithelial cancers that they are considered reliable biomarkers of the disease.(1)(2) 7
Despite their importance for diagnosis and prognosis, the mechanisms by which mucins 8 might promote malignancy remain largely speculative.(3) To date, the majority of studies 9
exploring the role of mucins in determining tumor phenotype have focused on the 10 signaling function of these molecules, which resides within their short cytoplasmic tail. 11
Yet, a striking and defining feature of cell surface mucins is their long, densely 12 glycosylated ectodomain, which can extend hundreds of nanometers from the plasma 13 membrane.(4) Consequently, mucins can profoundly enhance the bulk physical properties 14 of the glycocalyx, which is a composite of the polysaccharides and glycoproteins that 15 project from the plasma membrane and decorate all cells. 16 We recently showed that the bulk physical properties of the glycocalyx can exert 17 profound effects on cellular behavior. These effects include a reorganization of cell 18 surface receptors such as integrins. This reorganization alters their activation state and 19
influences not only their ability to interact with extracellular matrix (ECM) ligands but 20 also their synergistic downstream signaling with growth factor receptors. (5, 6) By 21 occluding the majority of binding sites, an expansive glycocalyx paradoxically promotes 22
integrin clustering by creating a kinetic funnel in which integrins are most likely to bind 23 to the ECM where bonds are already formed. (7) In this regard, in vitro studies revealed 1 that increasing the bulkiness of the glycocalyx enhanced the ability of nonmalignant 2 mammary epithelial cells to grow and survive under minimally adhesive conditions 3 whereas otherwise the cells underwent anoikis. (5, 8, 9) Whether a bulky glycocalyx 4 similarly modulates cell growth and survival in vivo, however, has yet to be 5 unambiguously tested. 6
Importantly, we and others have also noted that tumor aggression is frequently 7 associated with an increased expression of mucins which enhance the bulkiness of the 8 glycocalyx and, similarly, that circulating epithelial tumor cells typically express an 9 abundance of mucins. (5) Concomitantly, primary tumor xenografts that overexpress 10 MUC1 grow and metastasize more aggressively (10) and mice deficient in MUC1 resist 11 formation of spontaneous tumors (11) . Together, these observations raise the intriguing 12 possibility that tumor associated mucin expression may foster tumor progression and 13 aggression by enhancing either tumor cell growth and survival or both by modulating 14 integrin and growth factor receptor signaling. 15
Herein, we report that increasing the thickness of the glycocalyx promotes tumor 16 metastasis by permitting cell cycle progression to facilitate cell proliferation at the 17 metastatic site. We modulated glycocalyx thickness both genetically through ectopic 18 expression of a tailless (signaling defective) MUC1 and more definitively by coating cells 19 with synthetic glycopolymers with long-term cell surface retention that were designed to 20 emulate the structure of mucin ectodomains (Fig. 1A) .(8) The longevity of the synthetic 21 glycopolymers was facilitated by developing the chemistry so that the tail terminated in a 22 cholesterylamine lipid at one end, which effectively drives spontaneous insertion into cell 23 1 checks to their irregular growth -limited not only by ability to disseminate but also to 2 survive and thereafter to grow and expand at the metastatic site. The nonmalignant 3 mammary epithelial cell line, MCF-10A, offers a unique model for oncogenic 4 progression.(15) These cells, though immortal, lack the ability to grow or survive 5 efficiently in a soft matrix, and therefore serve as an ideal cell line to evaluate the effects 6 of the glycocalyx on mammary epithelial cell behavior in the context of a metastatic 7 site. (16) Our prior studies suggested that a bulky glycocalyx permitted not only the 8 survival but also the growth of these mammary epithelial cells in an in vitro model of a 9 minimally adhesive microenvironment. Thus, we asked whether a bulky glycocalyx 10 would permit both the survival and the growth and expansion of disseminated mammary 11 epithelial cells in vivo. MCF-10A cells were painted with our glycopolymers, then 12 injected into the venous system of nude mice, where they accumulated in the lungs 13 regardless of glycopolymer length. We found that those cells treated with long 14 glycopolymer mucin-mimetics survived longer, as demonstrated by delayed activation of 15 the apoptosis marker cleaved caspase-3 (CC3), than those decorated with short 16 glycopolymers (Figure 1-figure supplement 1), consistent with our in vitro studies. 17
Nevertheless, the cells eventually died and therefore ultimately failed to form metastatic 18 lesions, leaving us unable to determine the potential effect of the glycocalyx on 19 proliferation. Thus, to unambiguously address whether or not a bulky glycocalyx might 20 influence tumor behavior and metastasis by regulating cell proliferation, independent of 21 cell survival, we assessed the influence of the glycopolymers on the growth and 22 metastatic efficiency of the dormant-prone tumor cell line from the syngeneic 1 4TO7/Balbc model. 2
The murine cell line 4TO7 is a Balb/c syngeneic mammary carcinoma that is able 3 to efficiently disseminate and survive for prolonged periods of time at metastatic sites 4 such as the lung.(17) However, the tumor cells in this model form predominately dormant 5 tumors because they are unable to proliferate efficiently at the target site. These 4TO7 6 cells, therefore, provided us the ideal model to specifically address the contribution of a 7 bulky glycocalyx on cell proliferation and G1 cell cycle transit in vivo. 8 9
The glycocalyx increases metastatic potential in a size dependent manner 10 We first confirmed that the mucin-mimetic glycopolymers were long-lived on 11 4TO7 cell surfaces in culture, as previously found with other cell lines ( Fig. 1B) .(8) Next, 12
we grew mCherry-luciferase fusion-transfected 4TO7 cells to subconfluency, painted 13 them with glycopolymers, then injected them into the tail veins of Balb/c mice (Fig. 1C) . 14 Veins lead directly to the right heart where cells next meet the capillary beds of the lungs 15 and are lodged. Every 4-5 days mice were anesthetized and given an intraperitoneal (IP) 16 injection of luciferin for bioluminescence imaging (BLI) ( Fig. 1D ). By day 13, mice 17 injected with 4TO7 cells coated with long glycopolymers were generating greater photon 18 flux, on average, than their counterparts injected with short glycopolymer-treated cells, 19
suggesting a higher density of luciferase-expressing cells and thus an increased tumor 20 burden (Figs. 1D and 1-figure supplement 1). In particular, we noted that the increase in 21 BLI over time in the long glycopolymer group appeared to approximate an exponential 22 growth-type trend, while the short group did not ( Fig. 1-figure supplement 2) . 23
Importantly, we measured no significant difference in accumulation of tumor cells in the 1 lungs between treatment groups as measured by BLI at Day 0. 2 On day 15, the mice were sacrificed and necropsies were performed. We observed 3 gross differences in tumor burden between glycopolymer treatment groups (compare 4 Figures 1E and 1F ). Lungs were weighed wet then fixed in 4% paraformaldehyde and 5 embedded in paraffin wax for whole histological sectioning. Hematoxylin and eosin 6 (H&E) staining revealed qualitative differences in tumor burden, and 7 immunohistochemistry (IHC) staining for mCherry confirmed that tumors were derived 8 from exogenous mCherry-luciferase transfected 4TO7 cells and did not arise de novo 9
(Figs. 1G and 1H). 10
Lung tissue is spongy and consists of an abundance of negative space that can be 11 filled with air during respiration. Tumors, by comparison, are dense and contain 12 relatively little negative space. Consequently, in a vein-to-lung model of metastasis, lung 13 mass can be a strong indicator of tumor burden. We found that the lungs of mice injected 14 with 4TO7 cells endowed with a bulky glycocalyx were significantly heavier than lungs 15 from mice injected with short glycopolymer-bearing cells (Fig. 1I ). In addition to mass, 16
we directly quantitated the number of mets per lung. For each mouse, we counted every 17 met in the whole lung H&E section taken 5 millimeters (mm) into sectioning. Long 18 glycopolymer-treated 4TO7 cells produced, on average, more than twice the number of 19 mets per mouse when compared to short ( Fig. 1J ). Thus, merely increasing the thickness 20 of the glycocalyx was sufficient to increase the metastatic potential of otherwise poorly 21 metastasizing murine carcinoma cells. Importantly, the short glycopolymers did not 22 increase the metastatic potential of 4TO7 cells when compared to mock (PBS) treated 23 8 cells ( Fig. 1-fig. supplement 3) . Metastasis is an inefficient process-few circulating 1 tumor cells actually give rise to metastatic tumors-and the prevailing view is that 2 survival and proliferation at the secondary site is rate limiting.(18) Therefore, we 3 wondered if this increased metastatic potential could be due to increased growth, 4 survival, or both. 5
Quantitative immunofluorescence (IF) imaging of phosphorylated histone H3 6 (pH3)-a marker of mitosis-and cleaved caspase-3 (CC3)-a marker of apoptosis-7 revealed that mets from long glycopolymer-treated cells had higher rates of proliferation 8 than those from cells treated with short glycopolymers (Figs. 1K and 1L). But, the rates 9 of apoptosis were similar (Figs. 1K and 1M). While surprising at first, given our 10 knowledge that a thick glycocalyx improves survival in minimal adhesion settings, we 11 reasoned that by day 15 the survival phenotype had likely run its course-cells unable to 12 survive in that niche may have died days earlier. These data corroborated our BLI results 13 and indicated that the glycocalyx likely affects metastatic proliferative competency in 14 vivo. 15
16

A thick glycocalyx drives cell cycle progression via the PI3K-Akt axis 17
To gain mechanistic insight into this apparent proliferative effect, we tested the 18 effects of modulating glycocalyx thickness on cell growth in a soft matrix in vitro model. 19
We used fibronectin-functionalized polyacrylamide (PA) gels whose stiffness can be 20 controlled by varying both acrylamide concentration and crosslinking frequency. (19) We 21
painted MCF-10A cells with short or long mucin-mimetic glycopolymers, or with vehicle 22 (PBS), then plated them at low density on fibronectin-functionalized soft PA gels 23 (Young's modulus = 400 Pa) so that nearly all cells were isolated, minimizing cell-cell 1 interactions. After 72 hours, we imaged the gels and quantified the number of cells in 2 each observed colony. The long glycopolymer-painted cells formed colonies with, on 3 average, twice as many cells as colonies formed by the short glycopolymer-treated cells 4 or PBS-treated controls (Figs. 2A-C). And the percentage of colonies growing beyond 5 two cells nearly tripled for long-glycopolymer-treated cells verses PBS-treated controls, 6
indicating that this increase in mean colony size was not due merely to a few large 7 colonies ( Fig. 2D ). 8
To test that this phenotype required cell-surface residence of the long 9 glycopolymers, we compared the effects of the cholesterylamine-anchored molecules, 10 which persist on the plasma membrane for several days even after cell division, with 11 those of a phospholipid-functionalized glycopolymer that is lost from the cell surface 12 within several hours.(8) Cells treated with these short-lived but equally long 13 glycopolymers did not produce larger colonies compared to PBS treatment alone ( To further test our hypothesis that a bulky glycocalyx permits proliferation in the 17 metastatic niche, we analyzed markers of cell cycle progression. Cells were painted with 18 short or long glycopolymers, or with vehicle (PBS), then plated on either soft (Young's 19 modulus = 400 Pa) or stiff (Young's modulus = 60,000 Pa) fibronectin-functionalized PA 20 gels, the latter being a positive control for integrin activation.(20) After allowing them to 21 adhere for 6 hours, cells were lysed and the lysates analyzed by immunoblotting. We 22 found that cells plated on stiff PA gels, which offer a rich adhesion setting, produced 23 higher levels of cyclin D (a protein required for cell cycle progression) and showed 1 higher levels of pH3 than those on adhesion-poor soft gels ( Fig and pH3 levels, compared to short glycopolymer-and PBS-treated cells, even on soft 4 gels, suggesting that a thick glycocalyx drove proliferation and cell cycle progression in 5 this poor adhesion setting. 6
Integrin activation and growth factor signaling form, in logic terms, an "AND 7 gate" for cell cycle progression in nontransformed cells. (21) We sought to determine 8 whether a bulky glycocalyx alters this fundamental control mechanism. After serum-9
starving MCF-10A cells for 72 hours, we lifted them, painted them with long or short 10 glycopolymers, or with vehicle. The cells were plated on gels as in Figure 2E , except now 11 in serum-free media, and then lysed after 6 hours. A lack of growth factor signaling 12 reduced cyclin D1 and pH3 levels to below the detection limit, even when cells were 13 grown on stiff gels or endowed with a bulky glycocalyx (Fig. 2F ). The underlying drivers 14 of proliferation therefore, including growth factor signaling requirements, appeared to be 15 unaltered by glycocalyx thickness in this model. 16
To discern the factors responsible for increased cell cycle progression of cells 17
with thicker glycocalyces, we examined Erk and Akt, the mitogen activated protein 18 kinases (MAPKs) thought to be central to adhesion-mediated control of cell cycle 19 progression.(22) After serum starvation for 72 hours, cells were coated with 20 glycopolymers or vehicle, and plated on PA gels in serum-free media for 6 hours. The 21 cells were then challenged with epidermal growth factor (EGF) for 15 minutes and then 22 lysed. A bulky glycocalyx increased Akt phosphorylation, a proxy for activation, on soft 23 gels to a level that was comparable to that observed from cells on stiff gels ( Fig. 2G and 1 Next, we sought to test our hypothesis that this phenotype is driven by integrin-18 focal adhesion kinase (FAK) signaling. FAK disseminates adhesion information from 19 focal adhesions to the rest of the cell via autophosphorylation at tyrosine 397, as well as 20 increased phosphorylation at tyrosine 925, presumably through Src kinase activation.(23) 21
Western blotting with phospho-specific antibodies revealed that possession of a thick 22 glycocalyx led to enhanced activation of FAK ( Fig. 3A and Fig. 3-fig. supplement 1) . 23
These effects on FAK were mirrored by adhesion of untreated cells to a stiff matrix. By 1 contrast, cells coated with short glycopolymers, or untreated cells, plated on a soft matrix 2 showed comparatively less phosphorylation on FAK. Reciprocally, cells treated with long 3 glycopolymers along with a nonlethal dose of a specific inhibitor of FAK were unable to 4 form colonies on soft matrices, whereas vehicle (DMSO)-treated, long glycopolymer-5 coated cells retained colony forming activity ( Fig. 3B ). 6
To determine whether enhancement of adhesion signaling due to a bulky 7 glycocalyx also occurs in vivo, we probed FAK phosphorylation status in the mets from 8 The MUC1 ectodomain is sufficient to increase the metastatic potential of 4TO7 19
cancer cells 20
Lastly, for physiological relevance, we evaluated the effects of a natural mucin 21 ectodomain on the metastatic potential of 4TO7 cells. We utilized a cytoplasmic 22 truncation of MUC1 (MUC1ΔCT), the mucin most commonly overexpressed in breast 23 and ovarian cancers, to limit any cytoplasmic signaling which might confound our 1 results. We transfected mCherry-luciferase expressing 4TO7 cells with MUC1ΔCT under 2 the control of a doxycycline (dox)-inducible promoter. We grew these cells to 3 subconfluence, treated them with doxycycline (200 ng/ml) or vehicle (PBS) for 24 hours, 4 then lifted them and immediately injected them into Balb/c mouse tail veins (Fig. 4A ). As 5 previously, mice were monitored every 4-5 days via BLI measurements and sacrificed on 6 day 15. 7 BLI photon flux revealed that MUC1ΔCT-expressing cells formed mets that were 8 growing more rapidly than those formed from MUC1ΔCT-negative cells ( Fig. 4-figure  9 supplement 1). Whole lung sectioning, H&E staining and IHC on mCherry revealed a 10 dramatic qualitative difference in tumor burden ( Figs. 4B and 4C ). Wet lung mass was 11 nearly doubled in mice injected with MUC1ΔCT-expressing cells versus control (Fig.  12   4D) . Nearly three times the number of mets were formed in the lungs of mice injected 13 with cells expressing the mucin ectodomain compared to those that were not (Fig. 4E) . It should be noted that in addition to their physical influence, the glycans on 21 mucins have been found to participate in biochemical interactions. For example, 22 sialylated mucin-associated glycans engage the Siglec family of immunomodulatory 23 receptors and may therefore tune the response of critical effector cells in the tumor 1 microenvironment.(30-32) Thus, mucins' influence on cancer likely reflects many 2 functional modalities, each contributing differentially to various facets of disease 3 progression. From this vantage point, mucins are prime targets for therapeutic 4 intervention and warrant increased focus on avenues for their disruption. The authors would like to thank Dr. Jon Lakins for the rtTA lentiviral vector. We would 8 also like to thank Drs. Ori Maller, Dwight Chambers, and Brian Belardi for helpful 9 discussions. This work was funded by a grant from the US National Institutes of Health 10 (R01GM59907). ECW was supported by a predoctoral fellowship (F31CA200544). 11
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Materials and Methods 13
Mucin-mimetic glycopolymers 14
Glycopolymers were synthesized as previously described (8). Briefly, lipid-conjugated 15 RAFT agents were synthesized, from which methyl vinyl ketone was polymerized, to 16 generate polymers of various lengths with low polydispersities. The ketone pendant 17 groups were functionalized with alkoxy-amine containing N-acetylgalactosamine 18 monomers and purified to give the final lipid-terminated glycopolymers. 19 20
Cell culture 21
MCF-10As were acquired from ATCC (CLR-10317), met the published morphological 22 characteristics described on ATCC, used within 30 passages, confirmed to be 23 mycoplasma free, and maintained in recommended media: DMEM/F12 without phenol 1 red, supplemented to contain 5% horse serum (Invitrogen), EGF (20 ng/ml from 2 Peprotech), hydrocortisone (0.5 mg/ml from Sigma), cholera toxin (100 ng/ml from 3 Sigma), insulin (10 m g/ml from Sigma) and 1% penicillin/streptomycin. 4 5 4TO7 cells were a kind gift from Dr. Philip Owens (Vanderbilt University), met the 6 morphologic characteristics described on ATCC, used within 30 passages, confirmed to 7 be mycoplasma free and were maintained in DMEM with 10% FBS and 1% 8 penicillin/streptomycin. (pLV). Cells were selected with puromycin (1µg/mL) for purity then used as described 7 (33). puromycin (1µg/mL) for purity and then used as described (33). 16 17
Polyacrylamide cell substrates 18
Fibronectin-functionalized PA substrates were synthesized as described previously with a 19 few modifications. Briefly, methacrylate-functionalized cover glass was used with 20 dichlorodimethylsilane-functionalized cover glass to create a sandwich between which 21 PA gels were allowed to polymerize. Gels were functionalized with the 22 heterobifunctional molecule N6. Fibronectin then was conjugated to the gels via N6's 23 amine-coupling chemistry. Gels were rinsed and warmed with media before cells were 1 added. 2 3
Colony formation experiments 4
MCF-10A cells were lifted with trypsin, counted, then incubated with 10 µM polymers in 5 PBS or PBS alone at 10 7 cells per ml for 1 hour at room temperature. Cells were washed, 6 then brought up into warm media and plated onto fibronectin-functionalized substrates. 7
After 72 hours in culture, images were taken from 9 random fields of view each from two 8 technical replicate gels per experimental condition, and the experiment was replicated in 9 entirety thrice. 
Tail vein metastasis model 4
Mice were restrained and tail vein injections were performed with 100 µl at 10 6 cells per 5 ml. Mice were not fed doxycycline-Dox (+) cells were treated for 24 hours before 6 injections with 200 ng/ml in complete media. For bioluminescence imaging, mice were 7 injected i.p. with D-luciferin at 15mg/kg, anesthetized with 2.5% isofluorane and 8 luciferin was allowed to circulate for 10 minutes prior to live animal imaging on an IVIS 9
Spectum imaging system (PerkinElmer). Sample sizes were determined using a two-10 sample test, a power of 0.90, and a Type I error of 0.05 with data collected from pilot 11 studies. 12 13
Histology 14
Paraffin-embedded lung tissues were sectioned, deparaffinized, and stained with 15 hematoxylin and eosin before imaging. 16 17
Immunohistochemistry 18
Paraffin-embedded lung tissues were sectioned at 5 µm, deparaffinized, and rehydrated 19 using graded ethanol washes. Sodium citrate buffer was used for antigen retrieval. Paraffin-embedded lung tissues were sectioned at 5 µm, deparaffinized, and rehydrated 6 using graded ethanol washes. Sodium citrate buffer was used for antigen retrieval. 7
Sections were blocked with BSA then incubated with primary antibodies overnight. pH3 8 antibodies were from Cell Signaling Technology and used as recommended. Fluorescent 9 secondary antibodies were from Jackson ImmunoResearch and used as recommended. 10
Sections were wet-mounted then imaged by confocal microscopy. 11
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Quantification of immunofluorescence 13
After microscopy, images were analyzed using ImageJ software. DAPI-stained nuclei 14 were counted using the 'Analyze particles' tool. Signal from antibodies of interest was 15 measured using the 'Measure' tool set to output 'mean' pixel intensity. Quotients were 16
obtained by dividing either the number of positive nuclei (pH3) or mean pixel intensity 17 Frank mets were counted on whole lung sections at 5 mm into sectioning for each mouse and grouped according to glycopolymer 7 treatment type of injected cells. Data shown are mean ± SEM. n = 6 for PBS and n = 6 for Short. 
